New Year, new vaccines. And praise the universe for that! With the roll out of the vaccines, the dark shadows of the pandemic are beginning to lift. We can see the promised post-COVID-19 sunny uplands on the horizon. Three vaccines have so far been approved variously in the EU, US and UK. These are from...

Mesoblast Ltd. soars after getting a vote of confidence from large pharmaceutical backer Novartis AG on a stem cell medicine that was panned by U.S regulators just a month before. Novartis will pay an initial $25 million and invest another $25 million in Mesoblast stock in a deal securing global rights for remestemcel-L. The stem...